COVID-19: Newly Authorized Device From OraSure Subsidiary Allows At-Home Collection Of Saliva Samples
Executive Summary
The device is among the first that does not require a health care professional to supervise the saliva sample-collection process.
You may also be interested in...
Pentagon Forks Over Another $109M To Make OraSure’s COVID-19 Antigen Test
The latest funding would upgrade OraSure’s Pennsylvania plant, build a new factory and increase production of its antigen test by 100 million units by 2024.
DOD Contracts OraSure Rapid COVID-19 Tests For $205M
The US defense department’s Defense Logistics Agency will distribute the rapid antigen tests to 25,000 locations around the country to help stymie the spread of SARS-CoV-2 and its variants.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.